Here is the source of finasteride not blocking 5ar1 in humans btw, making rat studies inapplicable to them.
Although in humans FIN acts as a selective inhibitor of the peripheral 5AR type 2, in rats it is known to block efficiently both 5AR isozymes, and is in fact generally used to inhibit neurosteroid synthesis in rats (Concas et al, 1998; Finn et al, 2006).
npp200839.pdf (nature.com)
It is primarily an issue of DHT. Scalp tension is not a factor as was proven by the transplant studies where miniaturization of the hair follicles still occured even on other places of your body.
It’s what makes you feel great and is a primary muscle growth factor.
Naturally produced DHT is disabled in the muscle tissue so it is not a primary muscle growth factor, that is testosterone. And even assuming DHT has a role in mood regulation, finasteride is a selective 5ar2 inhibitor so it should not affect the DHT produced in your brain which relies on 5ar1.
@scta123
A twofold increased risk of sexual dysfunction was observed with the use of finasteride for treating androgenic alopecia compared to placebo in this meta analysis from 2019.
I am not denying side effects. What I am denying is the existence of persistent side effects which last even many months after cessation.
It is worth noting that there are several hypothesis about mechanisms that might persist after discontinuation of finasteride
There are strong association studies indicating that DHT is a risk factor for heart disease which is likely the primary driver in ED rates in older men too.
There is data from rat studies that show that finasteride produces long-lasting alterations in neuroactive steroids in rodent brains following discontinuation of finasteride. These findings indicate that finasteride treatment might have extensive implications for brain function.
In mice, finasteride is a strong dual 5ar1/2 inhibitor. In humans, finasteride is a selective 5ar2 inhibitor. The brain primarily contains 5ar1.
A human study compared histological foreskin findings in individuals experiencing permanent sexual symptoms six months after discontinuing finasteride with those who had not been previously exposed to 5α-reductase inhibitors. It revealed a difference in androgen receptor density between the two groups.
Also a rat study.
And probably I could find more data that shows that permanent and persistent changes are possible.
If you could find a study showing that in humans that would be great.